Oxic and hypoxic cells in a murine squamous cell carcinoma

Area of Science:

• Oncology
• Radiation Biology
• Cancer Research

Background:

• Tumor microenvironment heterogeneity, particularly oxygenation levels, significantly impacts cancer treatment efficacy.
• Understanding tumor cell kinetics and oxygenation status is crucial for developing effective therapeutic strategies.

Purpose of the Study:

• To investigate the in vivo kinetics and oxygenation status of squamous cell carcinoma cells using iododeoxyuridine ([125I]dU) labeling.
• To evaluate the effects of X-irradiation and misonidazole on tumor cell oxygenation and proliferation.

Main Methods:

• Labeling squamous cell carcinoma xenografts with [125I]iododeoxyuridine and tracking 125I activity over time.
• Utilizing [3H]thymidine autoradiography to map labeled cell distribution within the tumor.
• Inducing tumor hypoxia by leg clamping and assessing the impact of misonidazole and X-irradiation on 125I decay rates.

Main Results:

• A constant 125I activity was observed for 24-100 hours post-labeling, followed by a decline with a half-life of approximately 200 hours.
• Autoradiography revealed labeled cells migrating from capillaries through tumor cords to necrotic regions.
• X-irradiation shortened the constant 125I period and accelerated decay in a dose-dependent manner.
• Tumor hypoxia significantly decreased the 125I declining rate, while misonidazole increased it, even above oxic tumor levels.

Conclusions:

• Tumor cells transition from an initially oxic state post-labeling to becoming progressively hypoxic and anoxic as they move towards necrotic areas.
• The observed kinetics suggest a correlation between cell transit time, oxygenation status, and 125I decay.
• Radiation therapy and hypoxic radiosensitizers modulate tumor cell oxygenation and kinetics, influencing treatment response.